| Page 1437 | Kisaco Research
 

Kjetil Haga

Founding Partner
Bluefront Equity

Kjetil Haga

Founding Partner
Bluefront Equity

Kjetil Haga

Founding Partner
Bluefront Equity
 

Howard Tang

CEO
Peritus Capital

Howard Tang is CEO of Peritus Capital, a sustainability focused investment firm focused on supporting and financing the aquaculture, alternative protein, and renewable energy sectors.

Previously, Howard was with the Mergermarket Group (now Acuris), leading the company's global fixed income research and analytics team. He helped to grow the business into a billion-dollar company through multiple strategic and private equity exits.

Howard Tang

CEO
Peritus Capital

Howard Tang

CEO
Peritus Capital

Howard Tang is CEO of Peritus Capital, a sustainability focused investment firm focused on supporting and financing the aquaculture, alternative protein, and renewable energy sectors.

Previously, Howard was with the Mergermarket Group (now Acuris), leading the company's global fixed income research and analytics team. He helped to grow the business into a billion-dollar company through multiple strategic and private equity exits.

Howard then launched a business finance company called Simpler Funding that preceded an equity investment into Nordic aquaculture focused advisor. Howard eventually joined the latter full time as Managing Director and Head of Global Capital Markets; in this role he helped scale the firm into a global business, structuring complex financial solutions for some of the top seafood companies in the world.

Howard holds a CFA designation and Series 63, 7, 79, 24, and 27 licenses.

 

Larsen Mettler

Managing Director
S2G Ventures

Larsen brings over 17 years of experience in the oceans and finance sectors. Prior to joining S2G, Larsen was an owner and the Chief Financial Officer of Silver Bay Seafoods, a position he held since 2016.  Before joining Silver Bay, Larsen was a Director at KeyBanc Capital Markets where he led the firm’s Seafood Investment Banking and Corporate Lending practice. Larsen has also held various positions with the United Nations, the Executive Office of the President of the United States, and DoubleClick.

Larsen Mettler

Managing Director
S2G Ventures

Larsen Mettler

Managing Director
S2G Ventures

Larsen brings over 17 years of experience in the oceans and finance sectors. Prior to joining S2G, Larsen was an owner and the Chief Financial Officer of Silver Bay Seafoods, a position he held since 2016.  Before joining Silver Bay, Larsen was a Director at KeyBanc Capital Markets where he led the firm’s Seafood Investment Banking and Corporate Lending practice. Larsen has also held various positions with the United Nations, the Executive Office of the President of the United States, and DoubleClick. Larsen holds an MBA with a concentration in Investment Banking from Wake Forest and Dual BBAs in Finance and Information Systems from the University of New Mexico.

 

Oliver Viner

Chief Operating Officer
VetHelpDirect

Oliver Viner

Chief Operating Officer
VetHelpDirect

Oliver Viner

Chief Operating Officer
VetHelpDirect
 

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome

Larry Weiss

Chief Science and Product Officer
Symbiome
 

Kim Capone

Head, Microbiome Platform
Johnson & Johnson

Kim Capone

Head, Microbiome Platform
Johnson & Johnson

Kim Capone

Head, Microbiome Platform
Johnson & Johnson
 
The Pharma & Biotech Patent Litigation Summit, Europe
19-21 Jan 2026
Amsterdam, Beurs Van Berlage Centre
Welcome to Pharma and Biotech Patent Litigation 2025, Europe’s premier event for life sciences IP professionals. This January, join over 450 industry experts as we dive deep into the most pressing challenges and innovations in contentious IP law. Across three days of focused discussions and networking, you’ll gain valuable insights into the latest case law, regulatory updates, and strategic litigation approaches, while connecting with key stakeholders who drive the future of life sciences IP. 
 

Staffan Stromberg

CEO
Infant Bacterial Therapeutics

Staffan Stromberg

CEO
Infant Bacterial Therapeutics

Staffan Stromberg

CEO
Infant Bacterial Therapeutics